image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
efae2223879f53bdc05495b96d839694a943bd625ef6336988deff0aba8a999c.png | simple | <table><tr><td>Period</td><td>Ticks collected</td><td>Animals inspected</td><td>Infestation rate (%)</td></tr><tr><td>May-June (2014)</td><td>600</td><td>87</td><td>71</td></tr><tr><td>July-August</td><td>370</td><td>77</td><td>69</td></tr><tr><td>September-October</td><td>231</td><td>77</td><td>58</td></tr><tr><td>Nov... |
2f89a63b360d0a4a24ee43470161b016cd1b774b22d3308eeb932589c72a384c.png | simple | <table><tr><td>Scheme sponsorship</td><td>State</td><td>Recruitment method</td><td>Code</td></tr><tr><td>Private</td><td>Victoria</td><td>Direct contact with researcher</td><td>E1</td></tr><tr><td>Private</td><td>Victoria</td><td>Scheme</td><td>E2</td></tr><tr><td>Private</td><td>Victoria</td><td>Scheme</td><td>E3</td>... |
d31d6e9bf50023046bd5c402428aefb15168e03976ae41337b48cee98843b1b7.png | complex | <table><tr><td></td><td colspan="2"><underline>Model</underline></td><td colspan="5"><underline>Terms</underline></td></tr><tr><td><underline>Overall</underline><underline>Accuracy</underline></td><td><i>R</i><sup>2</sup> =</td><td><i>p</i> <</td><td></td><td>Tones</td><td>Clicks</td><td>Gabors</td><td>Music</td></t... |
0a4a4907c7ce81a7e02ca6bd1ad7cd9327d111e8c5ac2212ee47cd9d8b8d9ff9.png | complex | <table><tr><td rowspan="2">Connection Resiliency</td><td colspan="2">Self-Powered WSN</td><td colspan="2">MEDiSN</td></tr><tr><td>Failure Sequences</td><td>Elapsed Time (s)</td><td>Failure Sequences</td><td>Elapsed Time (s)</td></tr><tr><td>1</td><td>24</td><td>1500</td><td>18</td><td>600</td></tr><tr><td>2</td><td>552... |
9e312fd890f8e1df28047fb2ea36a976fbb174bead09d88f406d5184486f5256.png | complex | <table><tr><td>Subscale/Criterion</td><td colspan="3">Factor</td></tr><tr><td></td><td>1</td><td>2</td><td>3</td></tr><tr><td>SAWS critical life experience</td><td>0.047</td><td>0.702</td><td>0.220</td></tr><tr><td>SAWS emotional regulation</td><td>0.165</td><td>0.869</td><td>−0.007</td></tr><tr><td>SAWS reminisc... |
ac04eeaf93be8f6af15c36f5cff7b45543cde19359ba1ff021dfd07ef4b7d788.png | complex | <table><tr><td>Wound Infections</td><td>Non-Wound Infections</td></tr><tr><td>Cellulitis/Abscess (11/31)</td><td>Seromas (20/31)</td></tr><tr><td colspan="2">Pre-Operative Prophylactic Antibiotics</td></tr><tr><td>Cefazolin 8/11 (73%)</td><td>Cefazolin 16/20 (80%)</td></tr><tr><td>Clindamycin 1/11 (9%)</td><td>Clindamy... |
3284b3b5bf557636f0160c8b3c708f6e6a9e8dc385e4a7f850a18fb53208cd0e.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">CYP transcripts of <i>O. sanctum</i></td><td colspan="2">CYP transcripts of <i>O. basilicum</i></td><td rowspan="2">Functions</td></tr><tr><td><i>Arabidopsis</i>annotation</td><td>Lamiaceae annotation</td><td><i>Arabidopsis</i>annotation</td><td>Lamiaceae annotation</td><... |
5bbf5dce35795cb7db265652b56c9beee6906381424c130d05b472d90dcabe81.png | complex | <table><tr><td>Variable</td><td>All (<i>n</i> = 76)</td><td>Males (<i>n</i> = 36)</td><td>Females (<i>n</i> = 40)</td><td><i>p</i> (Males vs. Females)</td></tr><tr><td>Age (years)</td><td>34.8 ± 10.4</td><td>35 ± 18</td><td>36 ± 18</td><td>0.7549 <sup>a</sup></td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><... |
d0a6c71b114359c42d913129c75a2b750803ce04454f0eaf32805bbd306c1d0a.png | complex | <table><tr><td>Similarity searches</td><td colspan="2">Common molecules</td><td colspan="2">Common scaffolds</td></tr><tr><td></td><td>SF</td><td>GF</td><td>SF</td><td>GF</td></tr><tr><td>1</td><td>3705</td><td>7759</td><td>1821</td><td>3771</td></tr><tr><td>5</td><td>473</td><td>469</td><td>277</td><td>290</td></tr><t... |
f3ee19d469ad97304b924af0c0e5609bd01e15a2935f1da52056bda86cde8911.png | complex | <table><tr><td colspan="5"> </td></tr><tr><td colspan="5">i) 7 weeks old</td></tr><tr><td> </td><td> </td><td>+/+</td><td>m1/+</td><td>m1/m1</td></tr><tr><td colspan="2">No. of transplantation</td><td>9</td><td>24</td><td>10</td></tr><tr><td colspan="2">Tumor developed</td><td>9</td><td>24</td><td>4</td></tr><tr><td co... |
11b68edf484edb9fb28bc77013f2ade8dda68d2e1ccc2123652135bc9bb6287a.png | simple | <table><tr><td></td><td>dm-7-RR</td><td>RR</td><td>YR</td><td>dm-7-LR</td><td>LR</td><td>LY</td><td>LW</td><td>LF</td><td>Total MC</td></tr><tr><td>average</td><td>47</td><td>780</td><td>230</td><td>41</td><td>1700</td><td>840</td><td>300</td><td>580</td><td>3400</td></tr><tr><td>median</td><td>11</td><td>85</td><td>81... |
185b39153b68a4b2096e1e6155d8bbf0e5de0c6c49a5e4c41b971efdfeed4244.png | simple | <table><tr><td>Organism</td><td>Common name</td><td>Group</td><td>Annotation status</td></tr><tr><td>Acanthamoeba castellanii</td><td>Amoeba</td><td>BCM-HGSC<sup>a</sup></td><td>Server set up in progress</td></tr><tr><td>Helicoverpa armigera</td><td>Cotton bollworm</td><td>CSIRO<sup>b</sup></td><td>Server set up and an... |
1ce51fe8e0d3336b966702b0a4fd6bcc6c3485732da8e67dbe27f43bcfe782eb.png | simple | <table><tr><td>Characteristic</td><td>Adjusted Odds Ratio (95% Confidence Interval) for Remaining Uninsured for Entire Year</td></tr><tr><td>Child uninsured >6 months at baseline</td><td>3.8 (1.4, 10.3)</td></tr><tr><td>African-American/black race/ethnicity<sup>a</sup></td><td>2.8 (1.1, 7.3)</td></tr><tr><td>Male ch... |
6a70cc8a84a856cb9253a1001c18310f9a40edd3a520f04b03ea7d427faac171.png | simple | <table><tr><td></td><td>Density (kg/m<sup>3</sup>)</td><td>Thermal conductivity (W/(m °C))</td><td>Conductivity (S/m)</td><td>Specific heat capacity (J/(kg· °C))</td></tr><tr><td>Myocardium</td><td>1200</td><td>0.55</td><td>0.222</td><td>3200</td></tr><tr><td>Blood</td><td>1000</td><td>0.543</td><td>0.66... |
c109cc9a485a28c48693c29c4c3c8c4143dc6b0395f867d92e8d0ea8e8f1c37b.png | complex | <table><tr><td>Diet</td><td colspan="2">ALT</td><td colspan="2">AST</td></tr><tr><td> </td><td>Euthyroid</td><td>Thyroid alt</td><td>Euthyroid</td><td>Thyroid alt</td></tr><tr><td>Control</td><td>43.3 ± 24.73 <sup>ab</sup></td><td>38.5 ± 38.50 <sup>b</sup></td><td>151.6 ± 85.46 <sup>a</sup></td><td>94.4 ... |
109fd2c3da6ccd0fdd91a3d5b2ee6997b73741bd869a9fc21b93530a791e08b3.png | complex | <table><tr><td>Sample</td><td>Temperature (<sup>o</sup>C)</td><td><i>K</i><sub>F</sub> (mmol/g/kPa<sup>1/n</sup>)</td><td><i>n</i> (-)</td><td><i>r</i><sup>2</sup> (-)</td></tr><tr><td rowspan="3">ACF</td><td>25</td><td>0.1051</td><td>1.59</td><td>0.9998</td></tr><tr><td>40</td><td>0.0689</td><td>1.48</td><td>0.9998</t... |
7aa9a1ecff8157fe0df27be513e0401417376eb32d28c54bb54e50377c1643fc.png | simple | <table><tr><td>FGD</td><td>Age range at point of FGD</td><td>Mean age</td><td>No of participants</td><td>Male</td><td>Female</td><td>SCT</td><td>CT</td></tr><tr><td>FGD 1</td><td>13–15</td><td>13.5</td><td>6</td><td>4</td><td>2</td><td>4</td><td>2</td></tr><tr><td>FGD 2</td><td>15–17</td><td>15.7</td><td>7<... |
a7ee48afde8db3e31005bebb4245755781a12786c01f4fb89fb0a6f15740c7d7.png | simple | <table><tr><td>Pool code</td><td>Region: Site</td><td>Elevation (m)</td><td>Coordinates</td><td>Date</td><td>Pool size</td><td>Species</td><td>Virus detected</td></tr><tr><td>T1</td><td>Aegean: Canakkale</td><td>280</td><td>39°29'36.1"N, 26°19'26.7"E</td><td>08/2015</td><td>20</td><td><i>Cx. theileri</i></td>... |
140dd0f557d35c2ff6ce4339875221b4ba4597ea44468dd462b90669c3fd15ce.png | simple | <table><tr><td></td><td>Basal Metabolic Rate</td><td>Specific Heat</td><td>Blood Perfusion Coeff.</td><td>Thermal Conductivity</td></tr><tr><td></td><td><i>A<sub>o</sub></i></td><td><i>C<sub>p</sub></i></td><td>B</td><td>K</td></tr><tr><td></td><td>[J/(m<sup>3</sup> s)]</td><td>[J/kg °C]</td><td>[J/ (m<sup>3</sup>... |
f46c7abed5bd7d673c0065eb5d34ecbc04f8410aaa78a46301cc154bd2e060e7.png | simple | <table><tr><td>Item</td><td>Factor loading</td><td>Description</td><td>Original item no.</td><td>Initial factor</td><td>Mean (<i>SD</i>)</td><td>r<sub>item-total correlation</sub></td></tr><tr><td>1</td><td>0.722</td><td>Cuando tengo deseos intensos de comer, una vez que empiezo no puedo parar. [When I crave something,... |
79254f8dd04a47b387495f4040fe03905ef7cfffa45a5854e31a9909d0237aab.png | simple | <table><tr><td></td><td>Apixaban</td><td>LMWH/VKA/Placebo</td><td>Difference</td><td>Apixaban</td><td>LMWH/VKA</td><td>Difference</td></tr><tr><td>Number of events(total population)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Recurrent VTE and VTE-related death</td><td>514</td><td>577</td><t... |
e84cb3cb957a2bdb2e89d0c1fc990f46be013dffea3285c267d249adf0f89668.png | complex | <table><tr><td> </td><td>Participants (n)</td><td>Age mean (SD)</td><td>E-learning interest mean (SD)</td><td>E-learning experience mean (SD)</td></tr><tr><td rowspan="3">Prior clinical knowledge</td><td>Male (18)</td><td>26.16 (4.33)</td><td>4.33 (1.23)</td><td>3.72 (1.13)</td></tr><tr><td>Female (32)</td><td>24.56 (5... |
0577434b3bf12c43c07216b140f517b0c78d0cc70388c11fe82f8eb882d6f24c.png | simple | <table><tr><td>Assay</td><td>LK>LK Ri</td><td>DH44>LK Ri</td><td>DH44>DH44 Ri</td><td>LK>DH44 Ri</td></tr><tr><td>Effect of manipulation</td><td>Global LK knockdown</td><td>LK knockdown in ABLKs</td><td>Global DH44 knockdown</td><td>DH44 knockdown in ABLKs</td></tr><tr><td>Desiccation survival</td><td>͛... |
e2a3c19b4bc8afb4be52574ebbfb02f8160af2f7dfdf7770cf121e461e839a74.png | complex | <table><tr><td></td><td># G</td><td># loc</td><td>PPL</td><td>Br</td><td>Hj (S.E.)</td><td>F<sub>IS</sub></td><td>Filled seeds (%)</td><td>Seed viability (%)</td></tr><tr><td colspan="9"><i>Northwestern European J. communis populations</i></td></tr><tr><td>Cour</td><td>9</td><td>104</td><td>73</td><td>1.73</td><td>0.40... |
5702c2b93de8a373ece1a21fc4ce11277952248a2a24437e51135fb4f3c700ed.png | simple | <table><tr><td></td><td>TE1 (<i>n = </i>24)</td><td>TE2 (<i>n</i> = 22)</td><td>TE3 (<i>n</i> = 30)</td><td>TE4 (<i>n</i> = 25)</td></tr><tr><td>Condition</td><td>D</td><td>CN</td><td>D</td><td>CN</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td></tr><tr><td> Girls</td><td>11 (45.8%)</td><td>13 (59.1%)</td>... |
165282f8916b57a8e5736316a348fbd4f0fd27bdc18241c1036aea8bb26b7a54.png | simple | <table><tr><td> </td><td>Daytime</td><td>Nighttime</td><td>24 h</td></tr><tr><td>SBP</td><td> </td><td> </td><td> </td></tr><tr><td><i> Symptomatic</i></td><td>124.7 ± 25.2</td><td>131.2 ± 26.6</td><td>126.7 ± 25.1</td></tr><tr><td><i> Asymptomatic</i></td><td>123.1 ± 13.8</td><td>122.1 ± 19.9<... |
59af8ed3b2d87a9a55585d11fb9b523dc89a989fe19c61fa72cdcf5dbb023a41.png | simple | <table><tr><td>Domains</td><td>Patients n = 15</td><td>Controls n = 15</td><td>p-value</td></tr><tr><td>Somatisation</td><td>0.647 (0.496)</td><td>0.357 (0.366)</td><td>0.005 (0.013)</td></tr><tr><td>Obsessive-Compulsive</td><td>0.670 (0.578)</td><td>0.447 (0.253)</td><td>0.14</td></tr><tr><td>Interpersonal sensitivity... |
1cd4a1b3ce5a89e313d43569cb4c907acb50d78f31f2b3ce0060e1b740d61fb1.png | complex | <table><tr><td>Time of assessment</td><td colspan="4">Survival</td></tr><tr><td></td><td>1 year</td><td>2 years</td><td>3 years</td><td>5 years</td></tr><tr><td>After day 28</td><td>33.0%</td><td>27.0%</td><td>23.9%</td><td>19.8%</td></tr><tr><td>After ICU discharge (male and female)</td><td>61.8%</td><td>50.6%</td><td... |
6b5c56005b1277976b58e369a1b506a9c6fefe939c227f0dce2eac76dbd440d2.png | simple | <table><tr><td></td><td>Antibiotic coated (n=31)</td><td>Antibiotic non-coated (n=40)</td><td>p</td></tr><tr><td>Mean age (years)</td><td>48.5</td><td>51.2</td><td>>0.05</td></tr><tr><td>Positive culture n (%)</td><td>4 (13)</td><td>14 (35)</td><td>0.002</td></tr><tr><td>Median follow-up (months)</td><td>29 (8 to 38... |
a6d4b957462d05261f8a107d3ef3bb6d4935100bf18ceb4cab40db0f8433a55d.png | simple | <table><tr><td>Gene</td><td>Gene information</td><td>GO term</td></tr><tr><td>APOLD1</td><td>Apolipoprotein L domain containing 1</td><td>Response to abiotic stimulus</td></tr><tr><td>ATP13A4</td><td>ATPase type 13A4</td><td>Transmembrane transport</td></tr><tr><td>ATP1A2</td><td>ATPase, Na+/K+ transporting, alpha 2 po... |
595a34d7b2508e0caa0003c7dfa640f206ec63c2be63a30d16161cc9d327d04f.png | complex | <table><tr><td colspan="4">Data flow stages</td></tr><tr><td>Tool</td><td>SQS</td><td>Action property</td><td>Activity(Yes or No)</td></tr><tr><td colspan="4">Data collection</td></tr><tr><td>Primary self-quantification tools</td><td>Digifit, BodyTrack and Wikilife</td><td>C</td><td>Yes</td></tr><tr><td>Primary self-qu... |
402be53c61f59c1ccd174aa8530654e1c20a9be912cdfb01d8589ab8db3877fb.png | complex | <table><tr><td rowspan="2"></td><td>Overall</td><td colspan="4">GFR category<sup>a</sup></td></tr><tr><td></td><td>G1</td><td>G2</td><td>G3a</td><td>G3b-G5</td></tr><tr><td>MDRD vs. CKD-EPIcrecys</td><td>16.7 (15.9%)</td><td>17.5 (15.1%)</td><td>16.1 (18.3%)</td><td>6.4 (11.1%)</td><td>2.2 (6.0%)</td></tr><tr><td>MDRD ... |
da5955e8f699351f114594074cc49f328c8e29763afd2519af4e541b475744cb.png | complex | <table><tr><td rowspan="2">Pneumococcal serotype</td><td rowspan="2">Twofold response to vaccination</td><td colspan="3">Post-vaccination anti-CP<sup>†</sup> antibody concentration</td></tr><tr><td>≥0.35 μg/mL</td><td>≥1.00 μg/mL</td><td>≥5.00 μg/mL</td></tr><tr><td>6B (n = 10)</t... |
227e873dde5ab40f2f8d59ae3ba91686e7af31c11ead3e62e80ac81b5c03cf10.png | simple | <table><tr><td>Probe ID</td><td>Symbol</td><td>Hazard Ratio</td><td>β</td><td><i>P</i> value</td><td>AUC</td></tr><tr><td>A_24_P21161</td><td>GPR85</td><td>0.368</td><td>−1.000</td><td>1.16E-05</td><td>0.7188</td></tr><tr><td>A_23_P215687</td><td>GPR85</td><td>0.135</td><td>−2.002</td><td>1.55E-05</td>... |
7fc7528f40e027002a80d361954eca7c9b24a11dea65e587e8b0fdb0c8495abb.png | complex | <table><tr><td></td><td colspan="3">Free-ranging</td><td colspan="3">Captive</td></tr><tr><td></td><td><i>N</i>*</td><td>Mean ± SD</td><td>Median (25th, 75th percentiles)</td><td><i>N</i></td><td>mean ± SD</td><td>Median (25th, 75th percentiles)</td></tr><tr><td>NDF</td><td>8</td><td>63.6 ± 6.5</td><td>6... |
f3a6f921fbe601f02d3cb38823b9b23388e9dbcd85267d855c4b93cb8b24e9a6.png | complex | <table><tr><td>Time segment in s</td><td colspan="2">Probe 1</td><td colspan="2">Probe 2</td><td colspan="2">Probe 3</td><td colspan="2">Probe 4</td></tr><tr><td></td><td><i>M</i></td><td>SE</td><td><i>M</i></td><td>SE</td><td><i>M</i></td><td>SE</td><td><i>M</i></td><td>SE</td></tr><tr><td colspan="9">CONTROL GROUP</t... |
1ae70c02260ed68db434515b8d95bdb382e1459b2a2a5d172f094181d28b3880.png | simple | <table><tr><td>Species</td><td>Reads/Contigs</td><td>Number </td><td>Average size (nt)</td><td>Total nt</td></tr><tr><td><i>B. tuediae</i></td><td>Raw reads</td><td>547,061</td><td>547</td><td>299,232,484</td></tr><tr><td></td><td>Trimmed reads</td><td>546,903</td><td>333</td><td>182,128,133</td></tr><tr><td></td><td>A... |
e54a97cb98b97db7fdc2a470e2330d6f9fb0c3a4d920f7d65e5df2646bcb3530.png | simple | <table><tr><td>Time seizure free after breakthrough seizure (months)</td><td>Number at risk</td><td>Risk of seizure in following 12 months. %</td></tr><tr><td>6</td><td>119</td><td>32 (28 to 36)</td></tr><tr><td>9</td><td>99</td><td>24 (21 to 27)</td></tr><tr><td>12</td><td>80</td><td>17 (15 to 19)</td></tr></table> |
65d55db0d472d06ef02f803dadb85d91856ff43fec9a8fa50fddf0d3f0b88475.png | complex | <table><tr><td></td><td>Variant</td><td>Total</td><td>CIN1</td><td>CIN2</td><td>CIN3</td><td>ICC</td><td>Adjusted OR<sup>a</sup>(95% CI)</td></tr><tr><td rowspan="6">HPV52</td><td>A1</td><td>2</td><td>0</td><td>0</td><td>2</td><td>0</td><td>-</td></tr><tr><td>A2</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td... |
bea3fc05414c6ad028bfcfa07112891ca7e38d45ccfc871683db56585e0cb51d.png | complex | <table><tr><td></td><td colspan="2">MZ twins</td><td colspan="2">DZ twins</td></tr><tr><td></td><td>Male</td><td>Female</td><td>Male</td><td>Female</td></tr><tr><td>Mean age</td><td>35.09 (15.27)</td><td>35.63 (15.20)</td><td>31.57 (13.98)</td><td>31.88 (13.45)</td></tr><tr><td>Mean HRS</td><td>5.85</td><td>5.5</td><td... |
6d0573cf83318a44e80c8d1f456e380da490e92f0cb1aef7f4d44b01031dec49.png | complex | <table><tr><td colspan="2">Cardiac contractility dP/dt (mmHg/sec)</td></tr><tr><td>Control</td><td>SHR</td></tr><tr><td>1622 ± 120</td><td>1056 ± 182*</td></tr></table> |
f3fb42ec152c5e4ee9a229784b8617cb619b65a426222f9381455c0bf3dd14bf.png | simple | <table><tr><td>Corpus</td><td>Named entity types</td></tr><tr><td>GE</td><td>Protein</td></tr><tr><td>ID</td><td>Protein, chemical, organism, Regulon-operon,</td></tr><tr><td> </td><td>two-component-system</td></tr><tr><td>EPI</td><td>Protein</td></tr><tr><td>DNAm</td><td>Protein</td></tr><tr><td>EPTM</td><td>Protein</... |
7fb7d890077712bcca14e699e46eb8cd1ed3fe447d0ccd2dcee6687913d1419d.png | simple | <table><tr><td></td><td>Homeless</td><td>Housed</td></tr><tr><td>Cause of death</td><td>N (%)</td><td>N (%)</td></tr><tr><td> HIV/AIDS</td><td>156 (78%)</td><td>905 (83%)</td></tr><tr><td> Hepatitis</td><td>41 (21%)</td><td>130 (12%)</td></tr><tr><td> Liver disease</td><td>39 (20%)</td><td>160 (15%)</td></tr><tr><td> S... |
197140f4a9a7c65f3aa00b70a07c018779b31ca188f6315392c996221ff13288.png | simple | <table><tr><td>Health Behaviour</td><td>Group</td><td>Net change%</td><td>Odds Ratio for change</td><td>95% CI</td><td>NNT#</td></tr><tr><td>Fish</td><td>Intervention</td><td>+7.06</td><td>1.37*</td><td>1.11-1.64</td><td>15</td></tr><tr><td> </td><td>Control</td><td>+0.84</td><td> </td><td> </td><td> </td></tr><tr><td>... |
b21ccf8ed811c10e0014ede06ebf30917d2b203241806b88c23d9070405a09e0.png | complex | <table><tr><td> </td><td> </td><td colspan="3">Male</td><td colspan="3">Female</td></tr><tr><td> </td><td>Group</td><td>N</td><td>Mean</td><td>SD</td><td>N</td><td>Mean</td><td>SD</td></tr><tr><td rowspan="3">Permissiveness</td><td>Non-Koreans in US</td><td>79</td><td>3.34</td><td>.860</td><td>140</td><td>3.25</td><td>... |
8c42b0dea89d2cdc8f427e8056ea9b584b30e9ad39e6f193ee1b01c0c5e8e3ce.png | complex | <table><tr><td colspan="3">miRNAs repressing NF-κB signaling</td><td></td><td></td></tr><tr><td>miRNA</td><td>Gene</td><td>Transcripts</td><td>CS</td><td>CSP</td></tr><tr><td>miR-24</td><td>MYD88</td><td>NM_001172569, NM_002468, NM_001172568, NM_001172567, NM_001172566</td><td>-0.319</td><td>95</td></tr><tr><td></... |
bd7e49dca1ae04f115a917b313d1d531db905d966eceee556818aaf26ada7f4d.png | simple | <table><tr><td>No</td><td>Compound name</td><td>Area (%)</td><td>No</td><td>Compound name</td><td>Area (%)</td></tr><tr><td>1</td><td>3-Methyl butanol</td><td>0.14</td><td>19</td><td>β-Phellandrene</td><td>0.34</td></tr><tr><td>2</td><td>Eugenol</td><td>1.33</td><td>20</td><td>α -Thujene</td><td>1.26</td></tr... |
f7fd38a3d19a91cd02e2b9eb7953afaea2d3e47e9c30f12470b3407efe93d023.png | complex | <table><tr><td colspan="2">Demographic variables</td><td>N</td><td>%</td></tr><tr><td>Gender</td><td>Males</td><td>409</td><td>55.5</td></tr><tr><td> </td><td>Females</td><td>328</td><td>44.5</td></tr><tr><td>Year</td><td>First</td><td>149</td><td>20.2</td></tr><tr><td> </td><td>Second</td><td>183</td><td>24.8</td></tr... |
c0da054f001c4c07d9cd8bc9be0ce9b0b1882a002379d9930a5507f3d35aca6f.png | complex | <table><tr><td> </td><td colspan="3">BALP (U/L)</td><td colspan="3">Dpd (nmol/L)</td></tr><tr><td> </td><td>Control</td><td>CDNR</td><td><i>P</i> value</td><td>Control</td><td>CDNR</td><td><i>P</i> value</td></tr><tr><td>Day −1</td><td>3.582 ± 1.207</td><td>3.473 ± 1.391</td><td>0.882</td><td>3.665 ... |
5ec7cdc42b9d5212053ba540a3ab1bc3efd4c34373d173eeb8d82bd28c258753.png | simple | <table><tr><td> </td><td>UP1</td><td>UP2</td><td>UPps</td><td>SO1</td><td>SO2</td></tr><tr><td>Number of analysed branches</td><td>1,257</td><td>14,326</td><td>1,298</td><td>1,807</td><td>13,374</td></tr><tr><td>Branches with ω < 1 (%)<sup>a</sup></td><td>1,144 (91.01)</td><td>12,515 (87.36)</td><td>993 (76.50)... |
d7ec06af1af13dd241ae8cdd48c6523de18bd1b88d6fa45553a9c3496a2fa206.png | simple | <table><tr><td> </td><td>Probe</td><td>Primer 1</td><td>Primer 2</td></tr><tr><td>APOA1</td><td>CTGCCAGAAATGCCGAGCCTG</td><td>CTTTGAGCACATCCACGTACA</td><td>GCCGTGCTCTTCCTGAC</td></tr><tr><td>APOB</td><td>CTGGATACCGTGTATGGAAACTGCTCC</td><td>CATTGCCCTTCCTCGTCTT</td><td>CCAGAGACAGAAGAAGCCAAG</td></tr><tr><td>CPS1</td><td>... |
7fb2dc8e5b89fead91ca3244610e129730c054610a9318dd6ba0527b99b98673.png | complex | <table><tr><td rowspan="3">Comorbid condition</td><td>Patients</td><td colspan="3">Age group [years]</td><td colspan="2">Gender [%]</td></tr><tr><td> </td><td><40</td><td>40–59</td><td>≥60</td><td>Male</td><td>Female</td></tr><tr><td><i>N</i> (%)</td><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td><i>n</i>... |
d49b4e3bb387ce2d4d4ed0bcc4e8433b0f746811daddaea5f27730aeb4d1f89a.png | simple | <table><tr><td></td><td>SVR (<i>n</i> = 251)</td><td>Response failure (<i>n</i> = 105)</td><td><i>P</i> values</td></tr><tr><td>Gender (males%)</td><td>145 (57.8)</td><td>52 (49.5)</td><td> 0.154</td></tr><tr><td>Age ≥ 40 years (<i>n</i>%)</td><td>123 (49.60)</td><td>80 (77.7)</td><td><0.001</td></tr><tr><td>I... |
74f2b3de868d229be3b97e93bb6729a33082e49b77f8d8f399a5b8a9d339c471.png | simple | <table><tr><td>Covariates</td><td>OR</td><td>95% CI</td><td><i>P</i>-value</td></tr><tr><td>Unemployment (<i>n</i>=131)</td><td>0.97</td><td>0.24-3.77</td><td>0.961</td></tr><tr><td>Light physical activity (hours/week)(<i>n</i>=130)</td><td>1.00</td><td>0.93-1.08</td><td>0.947</td></tr><tr><td>Moderate physical activit... |
f5d944707d3e0a64294eb06788662b09d8fcd7d2a35eebbed93c8b68ca3da2c8.png | complex | <table><tr><td>RT</td><td>Isolate name<sup><i>a</i></sup></td><td>RFLP type<sup><i>b</i></sup></td><td>IIIB-specific PCR<sup><i>c</i></sup></td><td colspan="5">Alleles at the following loci</td></tr><tr><td></td><td></td><td></td><td></td><td><i>recA</i></td><td><i>gyrB</i></td><td><i>fliC</i></td><td><i>cepIR</i></td>... |
b67f4703dd532ac261b91361f99f3a3fa62a1060fcc37e7b7deb3ccc2d2ad351.png | simple | <table><tr><td>Pathological target</td><td>Putative mechanism</td><td>Examples of supporting references</td><td>Form of MS most likely to benefit</td></tr><tr><td>T- and B-cells</td><td>Limit cell proliferation in the periphery and possibly in the CNS</td><td>Lederman et al., 1984</td><td>RRMS</td></tr><tr><td></td><td... |
0de8fe7c6a5737c21ecef57669276528b1b84ccdce9c818f18af63061eb9ad93.png | complex | <table><tr><td>Anatomical location</td><td colspan="3">Talairach coordinates</td><td>Volume (mm<sup>3</sup>)</td></tr><tr><td></td><td><i>x</i></td><td><i>y</i></td><td><i>z</i></td><td></td></tr><tr><td colspan="5">VOCALIZATIONS > ACTION SOUNDS (<i>P</i> < 0.001)</td></tr><tr><td>Left aSTG</td><td>−58</td>... |
cafa098d9ef03d8ebbee38cfb3879dae5d510008f08ee3db4db4501b8edf846b.png | complex | <table><tr><td rowspan="2">Variable factors<sup><i>a</i></sup></td><td>Eye irritationOR (95% CI)</td><td>General symptomsOR (95% CI)</td><td>Upper respiratoryOR (95% CI)</td><td>Skin symptomsOR (95% CI)</td></tr><tr><td><i>N</i> = 2587</td><td><i>N</i> = 2502</td><td><i>N</i> = 2483</td><td><i>N</i> = 2684</td></tr><tr... |
1fd1cb8eb8ca89f375846b96d297cb5c52d7769756923201024f5061ab0adf7f.png | complex | <table><tr><td rowspan="2">Treatment</td><td rowspan="2">Dose</td><td colspan="4">Analgesic response (mean time in seconds ± SEM)</td></tr><tr><td>30 min</td><td>60 min</td><td>90 min</td><td>120 min</td></tr><tr><td>Control (normal saline)</td><td>1.0 mL/kg</td><td>7.03 ± 0.44</td><td>7.34 ± 0.44</td><t... |
7b54900bff11b717766c269b0637f9e92024ed2b18d81e040d73e9754bde0dde.png | simple | <table><tr><td></td><td><i>n</i></td><td>CD8<sup>+</sup></td><td>CD19<sup>+</sup></td><td>CD3<sup>+</sup></td><td>CD4<sup>+</sup></td><td>NK</td></tr><tr><td>Case group</td><td>715</td><td>29.3 ± 11.6*</td><td>3.0 ± 2.7*</td><td>69.3 ± 11.9</td><td>35.1 ± 10.2</td><td>15.1 ± 8.3*</td></tr><tr><... |
09cffaf35e30d5cc69a1bbc32b932a35231bd693aa0a6d43ba9c277a49e4019d.png | complex | <table><tr><td>Gene with likely pathogenic variant</td><td colspan="3">Steroid-resistant nephrotic syndrome (number of patients)</td><td colspan="3">Haematuria/Alport syndrome (number of patients)</td></tr><tr><td>Age group*</td><td>≤18 years (n=209)</td><td>>18 years (n=46)</td><td>Total (n=255)</td><td>Ͱ... |
51c18b7e79062d7949da19e495a632471f436396fa6131f4847309781c5129be.png | complex | <table><tr><td rowspan="3"></td><td rowspan="3"></td><td colspan="4">Predicted class</td></tr><tr><td>Cluster 1</td><td>Cluster 2</td><td>Cluster 3</td><td>Cluster 4</td></tr><tr><td rowspan="4">Actual class</td><td>Cluster 1</td><td>199</td><td>49</td><td>1</td><td>25</td></tr><tr><td>Cluster 2</td><td>5</td><td>441</... |
112ac9cdb436ee0d761bcac6f012422e52f416c3c269297ef11eafcc4ce22532.png | complex | <table><tr><td>Extracted Plant</td><td>Extracted Part</td><td>IC<sub>50</sub> (mg/mL)</td><td>Lead Substance</td><td>Content (μg/mg)</td><td colspan="2">IC<sub>50</sub></td></tr><tr><td><i>Arbutus unedo</i> (strawberry tree)</td><td>fruit</td><td>n.d. <sup>1</sup></td><td>arbutin</td><td>20.0 ± 1.3</td><td>n.... |
b051cb06a413f6ac81c57d052c66958f516e7f874c4255e94be8a793bee51968.png | complex | <table><tr><td colspan="2">Control sheep (<i>n</i> = 18)</td><td colspan="2">Disease-stressed sheep (<i>n</i> = 10)</td><td colspan="2">Combined groups (<i>n</i> = 10 + 10)</td></tr><tr><td>Gene symbol</td><td>Stability value (<i>M</i>)</td><td>Gene symbol</td><td>Stability value (<i>M</i>)</td><td>Gene symbol</td><td>... |
7d6d3f55a48f7c51d691994a79622ab0054442db7e2b85e7f1a858291af741e9.png | simple | <table><tr><td></td><td>Guideline</td><td>Source</td></tr><tr><td>1</td><td>Use Dex/sal for MIF (unless documented why not)</td><td>NICE</td></tr><tr><td>2</td><td>Use fluid with 130–154mmol/l sodium for any resus</td><td>NICE</td></tr><tr><td>3</td><td>Receive 0.6-1.4mmol/Kg/day of maintenance sodium</td><td>NIC... |
988417ee791ab36b3648f35a228534566be3b8db30189b85ddef917503f73d34.png | simple | <table><tr><td></td><td>Protein Cnt</td><td>ID Cnt</td><td>Ambiguity</td></tr><tr><td>EPPI</td><td>6,955</td><td>184,633</td><td>26.55</td></tr><tr><td>EPPI species</td><td>6,955</td><td>17,357</td><td>2.50</td></tr><tr><td>TE</td><td>8,539</td><td>103,016</td><td>12.06</td></tr><tr><td>TE species</td><td>8539</td><td>... |
de76f5d5f48140d6fc1ec1234c9886e7bb01d73cbb08101526e414f3d790f9a9.png | simple | <table><tr><td>Parameter</td><td>ITS</td><td>trn<i>L</i>-<i>F</i></td><td>Combines</td></tr><tr><td>Number of accession</td><td>49</td><td>49</td><td>49</td></tr><tr><td>Range of sequence length (bp)</td><td>642–643</td><td>799–801</td><td>1442–1443</td></tr><tr><td>Characters of data matrix</td><td>6... |
59ec2086d8759e5ce7b2ae72cf28fe04b9c3f2ec2a8dea6d0938a6df5d44e703.png | simple | <table><tr><td>Hormonal tests</td><td>Values (normal range)</td></tr><tr><td>Plasmatic cortisol</td><td><39 nmol/L (126.8–656.5)</td></tr><tr><td>Plasmatic aldosterone</td><td>14.2 pg/mL (18–232)</td></tr><tr><td>Plasmatic renin</td><td>12.9 <i>μ</i>mU/mL (4–50)</td></tr><tr><td>Plasmatic nora... |
928992160a81ff8561be86c9de6acdbd540683d7779b367b237603f2c8c8fe1f.png | simple | <table><tr><td>GO ID</td><td>Molecular Function</td><td>Observed Gene Count</td><td><i>FDR</i></td></tr><tr><td>GO.0004702</td><td>receptor signaling protein serine/threonine kinase activity</td><td>15</td><td>3.13E-21</td></tr><tr><td>GO.0005515</td><td>protein binding</td><td>7</td><td>2.03E-05</td></tr><tr><td>GO.00... |
b0562fadf1c6d953105d1f905551195a61e8e3aff940a099be180055df4747eb.png | simple | <table><tr><td>Accession NO.</td><td>Strain name</td><td>Year</td><td>Province</td><td>Host</td><td>Length</td><td>Biological sample</td></tr><tr><td>KU641013</td><td>LN1401</td><td>2014</td><td>Liaoning</td><td>Chicken</td><td>2298 bp</td><td>Liver</td></tr><tr><td>KU645511</td><td>LN1402</td><td>2014</td><td>Liaoning... |
4d8a2d812ee4a68e418522e639cf28e16ff333d4b687f0f49eb1056f9ce80986.png | complex | <table><tr><td> </td><td colspan="2"><i>No community sports participation</i></td><td colspan="2"><i>Community sports participation</i></td></tr><tr><td> </td><td>No extracurricular school-based sports participation</td><td>Extracurricular school-based sports participation</td><td>No extracurricular school-based sports... |
576c209a37eef79ccf23d4c2046b9cf0bfbac9498d0cc669179524bee7c28ab7.png | simple | <table><tr><td>Country</td><td>Total number of notified TB cases</td><td>TB notification rate per 100 000</td><td>Number of notified TB in foreign<sup>a</sup></td><td>Percentage foreign</td></tr><tr><td>Bulgaria</td><td>2649</td><td>35.0</td><td>2</td><td>0.1</td></tr><tr><td>Estonia</td><td>329</td><td>24.5</td><td>58... |
314b96f06dc29dcfde04f8f97c2a8fdebb126262862258d005fb530f4b97de2d.png | simple | <table><tr><td>Antibiotic</td><td>MIC (μg/ml)</td></tr><tr><td>Ampicillin</td><td>9.8</td></tr><tr><td>Nafcillin</td><td>1.25</td></tr><tr><td>Ciprofloxacin</td><td>25</td></tr><tr><td>Nalidixic acid</td><td>312</td></tr><tr><td>Chloramphenicol</td><td>1.25</td></tr><tr><td>Minocycline</td><td>0.97</td></tr><tr><t... |
b114fb90dd28270264c81f12cd5c153394c5ac6bfd8dde402326e5de3aa5ea7c.png | simple | <table><tr><td>Rat</td><td>Target<sup>a</sup></td><td>Angle (°)<sup>b</sup></td><td>int. diam. (μm)<sup>c</sup></td><td>Volume (nL)<sup>d</sup></td><td>Survival (days)<sup>e</sup></td></tr><tr><td>18</td><td>OC2L/ParP</td><td>30</td><td>6.7</td><td>20</td><td>19</td></tr><tr><td>19</td><td>ParP</td><td>30</td... |
c251904934a12b6ca00bd55cc6484372552710bab0d3b65702558d5644dc000c.png | simple | <table><tr><td><i>State</i></td><td><i>State Policy Extensiveness*</i></td><td><i>Geographic Area</i></td></tr><tr><td>California</td><td>High</td><td>West</td></tr><tr><td>Georgia</td><td>Middle</td><td>Southeast</td></tr><tr><td>Illinois</td><td>Middle/Low</td><td>Midwest</td></tr><tr><td>Massachusetts</td><td>Low</t... |
5c0e315385e7086226e1a3663c27a3d874ca2a95734169aacaf4221a01f31169.png | simple | <table><tr><td></td><td>High worry (Group 1) <i>N</i> = 35</td><td>GAD community (Group 2) <i>N</i> = 28</td><td>GAD clients (Group 3) <i>N</i> = 32</td><td>Panic clients (Group 4) <i>N</i> = 24</td><td><i>F</i> (3, 113)</td><td><i>Partial η</i><sup>2</sup></td><td>Post hoc <i>p < .05</i></td></tr><tr><td>Atten... |
c22a4b87b78074eb9f62522ddb59b472e03f665a7325762067a5a7509d6d6fbe.png | simple | <table><tr><td>Antigen</td><td>Clone</td><td>Supplier</td><td>Dilution</td><td>Antigen retrieval</td></tr><tr><td>PR</td><td>Mouse Monoclonal, 16</td><td>Leica Microsystems</td><td>1:100</td><td>citrate</td></tr><tr><td>ER</td><td>Mouse Monoclonal, 6F11</td><td>Leica Microsystems</td><td>1:100</td><td>citrate</td></tr>... |
74047561f1069e6fff80a0b9f8e7fac0b49db56ba0f4452385594826f10a0ea3.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">Unadjusted OR (95% CI)</td><td>Model 1</td><td>Model 2</td><td>Model 3</td></tr><tr><td>Adjusted OR (95% CI)*</td><td>Adjusted OR (95% CI)*</td><td>Adjusted OR (95% CI)*</td></tr><tr><td>All Years</td><td>3.14 (2.74 to 3.60)</td><td>1.89 (1.65 to 2.17)</td><td>1.87 (1.62 ... |
bd45eebb9b2fa6a62c8ce27dc738264c9f2a65314d05b8319533e14f9dc87089.png | simple | <table><tr><td>Variables</td><td>Univentricular</td><td>Biventricular</td><td>P</td></tr><tr><td>PDA flow* (L/min/m<sup>2</sup>)</td><td>1.70 (0.56 to 2.53)</td><td>0.61 (−1.48 to 3.23)</td><td>0.0147</td></tr><tr><td>AAo flow (L/min/m<sup>2</sup>)</td><td>0.56 (−0.19 to 1.08)</td><td>1.82 (−0.16 to 2... |
e401cb80ce2fdaa397b12c900a7f2c8776b393a7141f7decfe12e39cfd02ddad.png | complex | <table><tr><td>Drug</td><td colspan="8">Paw volume increase over time (ml ± SD) and effect (% of negative control)</td></tr><tr><td></td><td>1 hr</td><td></td><td>3 hr</td><td></td><td>5 hr</td><td></td><td>7 hr</td><td></td></tr><tr><td>Saline</td><td>0.63 ± 0.09</td><td></td><td>0.92 ± 0.14</td><td></t... |
291e2dc77f329a57e20cd25fc622003cf8f7d67832a7baaa4c2cf3e9faba10c4.png | complex | <table><tr><td>Condition</td><td>SMM and M, number (%)</td><td>Maternal deaths</td></tr><tr><td>Peritonitis</td><td>58(30)</td><td>16</td></tr><tr><td>Hemorrhage</td><td>45(18.7)</td><td>10</td></tr><tr><td>Hypertensive disease</td><td>55(28.6)</td><td>9</td></tr><tr><td>Cancer</td><td rowspan="4">5(1.5)</td><td rowspa... |
6fc256cdf81fa2f652b884836bcafd647309b5302e90d7c7524dce68d01ecadc.png | complex | <table><tr><td>Source</td><td colspan="3">1</td><td colspan="4">2</td><td colspan="3">3</td><td>4</td></tr><tr><td>Farm</td><td>A</td><td></td><td></td><td>B</td><td></td><td>D</td><td>E</td><td>C</td><td>F</td><td></td><td>G</td></tr><tr><td>Health status</td><td>SPF</td><td></td><td></td><td>SPF</td><td></td><td cols... |
bd1d513d4ddfcfb333597d3b0d9c9120ad44dd3fe8a2b53145ee293628e1a057.png | complex | <table><tr><td rowspan="2" colspan="2">Variables</td><td colspan="5">At the time of enrollment</td><td colspan="5">Follow-up</td></tr><tr><td>Cluster 1</td><td>Cluster 2</td><td>Cluster 3</td><td>Cluster 4</td><td><i>P</i> value</td><td>Cluster 1</td><td>Cluster 2</td><td>Cluster 3</td><td>Cluster 4</td><td><i>P</i> va... |
b3555d8e7f4450a1b8bbe1dab67c955ca46a51cefe1bcc7eff40b27c440d7097.png | complex | <table><tr><td>Variable</td><td colspan="2">Group at the beginning of treatment</td><td colspan="2">Group at the definitive brace removal</td></tr><tr><td>Gender</td><td>Girls</td><td>87 (97%)</td><td>Girls</td><td>87 (97%)</td></tr><tr><td></td><td>Boys</td><td>3 (3%)</td><td>Boys</td><td>3 (3%)</td></tr><tr><td>Mean ... |
49448717939f80892141346ace198e444708f97e36c4fec6b644d079ab949d45.png | complex | <table><tr><td></td><td></td><td>Total <i>N</i> = 456 n (%)</td><td>RV + <i>N</i> = 201 n (%)</td><td>RV – <i>N</i> = 253 n (%)</td><td><i>p</i>-value</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>236 (51.9)</td><td>95 (47.3)</td><td>140 (55.6)</td><td rowspan="2">0.079</td></tr><tr><td>Female</td><td>... |
3337ae7f11afc42c3d98d6b146d8a0b96b1f0730538e80686cea663ea15379d8.png | complex | <table><tr><td>Characteristics</td><td>Metabolically Normal Obesity <i>n</i> = 114 (%)</td><td>Metabolically Abnormal Obesity <i>n</i> = 36 (%)</td><td><i>p</i>-value</td><td><i>p*</i></td></tr><tr><td>Age (years, median, range)</td><td>8,85 (5,92–11,10)</td><td>11,12 (9,93–13,36)</td><td>< 0,001</td><td... |
97c9b679db075d5aec99f64656064822db05c85148277e1781d16e4ea8e574ec.png | simple | <table><tr><td>Setting</td><td>Level</td><td>Type of participants</td><td>Type of interviews</td><td>Number of interviews</td></tr><tr><td>MoH</td><td>Principal</td><td>Policy makers</td><td>Key informant</td><td>3</td></tr><tr><td>HSB</td><td>Principal</td><td>Policy makers</td><td>Key informant</td><td>2</td></tr><tr... |
ebf13677b665771ac9063720e282b92898be723b97971b129cfdeb266c7f135d.png | simple | <table><tr><td> </td><td>SLE</td><td>HD</td></tr><tr><td>Number of cases</td><td>103</td><td>65</td></tr><tr><td>Number of visits (2 or more)</td><td>180 (60)</td><td>65 (0)</td></tr><tr><td>Mean age, years (range)</td><td>44 (25–68)</td><td>33 (19–59)</td></tr><tr><td>Sex, female/male/unknown, n</td><td>90... |
fcea627a7495eb2c475d7ddd556a2400078e898836b4b4018ae14bb654f66fc1.png | simple | <table><tr><td></td><td>Wildtype</td><td>Mahidolheterozygote</td><td>Chinese-4heterozygote</td><td>Kaipingheterozygote</td><td>Mahidolhomozygote</td><td>Mahidol-Canton</td><td>Total</td><td>Overall allelicfrequency ofall variants</td><td>Allelic frequencyof Mahidol variant</td></tr><tr><td>Sgaw Karen</td><td>91</td><td... |
bc8330868c514c6a28d4f8cf08952fb67a2d05df55cd6b0b0ceb63685a0c1262.png | simple | <table><tr><td>Therapeutic modalities</td><td>Frequency (%)</td></tr><tr><td>Concomitant radio-chemotherapy</td><td>66 (43.7)</td></tr><tr><td>Concomitant radio chemotherapy followed by surgery</td><td>22 (14.9)</td></tr><tr><td>Exclusive radiotherapy</td><td>12 (7.9)</td></tr><tr><td>Surgery followed by exclusive radi... |
78775b711fce5c985b91ad482602f653f95879b7e52fe5047c6e70aa32cc3715.png | simple | <table><tr><td>Description</td><td>Notation</td><td>Baseline value</td><td>Reference</td></tr><tr><td>Population size</td><td><i>N</i></td><td>100,000</td><td>assumed</td></tr><tr><td>Average life expectancy at birth</td><td>1/<i>μ</i></td><td>69.4 (years)</td><td>[1]</td></tr><tr><td>Transmission coefficient of o... |
06575bc04911d377bf3c51c4039db123d233e83f0f4513f11d84cfdba92d9b3f.png | complex | <table><tr><td></td><td>Curative or not</td><td>N</td><td>Mean</td><td>Std. deviation</td><td>Std. error mean</td></tr><tr><td colspan="6">Group statistics</td></tr><tr><td rowspan="2"> Total HNA score</td><td>Curative</td><td>3671</td><td>26.08</td><td>34.312</td><td>.566</td></tr><tr><td>Not curative</td><td>1293</td... |
aaf3d30cafe71a5e6876befec0bebb429c0cd05afc7b5281db23c4ee9f4dab5d.png | complex | <table><tr><td rowspan="2">Sample</td><td colspan="2">Litter Concentrations</td><td colspan="2">Application Rates</td><td rowspan="2">Analyst</td></tr><tr><td>Fe</td><td>As</td><td>Fe</td><td>As</td></tr><tr><td>Litter from 2012</td><td>2200 ± 252</td><td>2.5 ± 3.0</td><td>7.41</td><td>0.009</td><td>This stud... |
877ab340d7cd3e6024ea94747b3b88d175a12c0fb513dc25e2c2c02932f33f2c.png | simple | <table><tr><td></td><td>TGCT</td><td>HD</td><td>NHL</td><td>L</td><td>S</td><td>BT</td><td>Behcet</td><td>MS</td></tr><tr><td><i>n</i></td><td>2315</td><td>1175</td><td>439</td><td>360</td><td>208</td><td>40</td><td>68</td><td>73</td></tr><tr><td>Age (year, median)</td><td>28.8</td><td>26</td><td>28.8</td><td>27.5</td>... |
0381e7afae7e242f60a060c821c3391d88f13728c1b8e234452335d1223ff1fd.png | simple | <table><tr><td>Time between onset of symptoms and care at CAMH clinic</td><td>n (%)</td></tr><tr><td>Within a week</td><td>29 (17.5)</td></tr><tr><td>More than a week but less than a month</td><td>7 (4.2)</td></tr><tr><td>1–6 months</td><td>50 (30.1)</td></tr><tr><td>7–12 months</td><td>22 (13.2)</td></tr><... |
ac5884b275e1a0055b43ba27cb67c03bf4be3a2229eccaed3fa3fac3932178cd.png | simple | <table><tr><td>Characteristics</td><td><i>N</i> (%)</td></tr><tr><td>Sex</td><td> </td></tr><tr><td> Male</td><td>1087 (53.9%)</td></tr><tr><td> Female</td><td>931 (46.1%)</td></tr><tr><td>Age (years)</td><td> </td></tr><tr><td> <3</td><td>65 (3.2%)</td></tr><tr><td> 3 to <4</td><td>294 (14.6%)</td></tr><tr><td> ... |
9378b42cba512297ab323465c27429193f9a096a2bfe31c21e094e4e4b3721f5.png | simple | <table><tr><td>Item</td><td>Concentrate mix (%)</td><td>Rye straw (%)</td><td>BF-based silage<sup>2)</sup> (%)</td></tr><tr><td>Dry matter</td><td>87.9</td><td>90.0</td><td>58.3</td></tr><tr><td>Organic matter</td><td>91.7</td><td>95.4</td><td>88.5</td></tr><tr><td>Crude protein</td><td>16.4</td><td>4.2</td><td>16.9</t... |
47bc4c054e3d92e8494f5d5258653726d35d13749c00c22b99001cfab993a4bc.png | complex | <table><tr><td>Township</td><td>Population Density</td><td>Population</td><td colspan="4">Area Percentage of TRs > 10<sup>−5</sup></td><td colspan="4">Area Percentage of TRs > 10<sup>−4</sup></td></tr><tr><td></td><td>(Person/km<sup>2</sup>)</td><td>(Person)</td><td>F1</td><td>F2</td><td>F3</td><td>F4... |
cf768a9f8e968a50888bed7d41728b391cfa5da95794cefce572b6f0725007ff.png | simple | <table><tr><td>Linkage group</td><td>Length (cM)</td><td>Number of markers</td><td>Number of bins</td><td>Largest gap (cM)</td><td>Mean gap size (cM)</td></tr><tr><td>LG1</td><td>479.62</td><td>999</td><td>196</td><td>16.70</td><td>2.46</td></tr><tr><td>LG2</td><td>475.13</td><td>1032</td><td>242</td><td>17.87</td><td>... |
20e1b61d86c99734872acc27bef4e1ede7c86eb2ff77c4af8bab2b4fb022bc30.png | complex | <table><tr><td rowspan="2">Collection time</td><td colspan="4">Pollen viability (%)</td></tr><tr><td>A</td><td>G</td><td>M</td><td>Q</td></tr><tr><td>05:00–06:00</td><td>20.2 ± 1.1a</td><td>16.2 ± 1.2a</td><td>11.9 ± 2.1a</td><td>15.5 ±1.6a</td></tr><tr><td>06:00–07:00</td><td>15.9 ±... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.